M sales up 11% as EBITDA margin reaches 16.4%
M reported sales up 11% and EBITDA margin at 16.4%, with robust growth in clinics and corporate segments.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.